Kaposi's sarcoma (KS) -associated herpesvirus/human herpesvirus type 8 (KSHV/HHV-8) may play an etiologic role in the pathogenesis of KS. In an attempt to assess KSHV/HHV-8 infection, an ELISA was developed using an 18 -amino acid peptide from a putative minor capsid protein of KSHV/HHV-8 conjugated to bovine serum albumin. Overall, sera from human immunodeficiency virus type 1 (HIV-1) -positive patients with KS had a higher reactivity in the assay than did sera from HIV-1 -positive patients without KS (P Å . The wide variation in the incidence of Kaposi's sarcoma rials for viral sequences by PCR. PCR-based assays require that the specific tissue being examined contain viral genomes (KS) among particular human immunodeficiency virus type 1 (HIV-1) -infected risk groups and other epidemiologic eviand, therefore, can fail to detect virus when viremia is intermittent or there are low genome copy numbers [5] . Moreover, as dence has suggested KS might be caused by an infectious agent [1, 2] . The recent discovery of KS-associated herpesvirus/ pointed out by others, the ease of sample contamination provides another potential drawback of PCR [11 -13]. human herpesvirus type 8 (KSHV/HHV-8) and the detection of its DNA in nearly all KS lesions from people with AIDS A specific and sensitive serologic assay for antibodies to KSHV/HHV-8 would reveal the demographics of infection and people in other patient groups [3] have provided evidence that this virus plays an important role in the pathogenesis of with this virus without regard to disease manifestations or sites of infection. Development of a serologic assay has been hin-KS. Further evidence of its etiologic relationship to KS was provided by the observation that detection of KSHV/HHV-8 dered by the significant sequence homology between KSHV/ HHV-8 and Epstein-Barr virus (EBV). Expression of KSHV/ DNA in peripheral blood mononuclear cells (PBMC) of HIV-1 -positive patients by polymerase chain reaction (PCR) HHV-8 antigens in HBL-6 cells along with the removal of EBV -cross-reactive antibodies allowed the development of an is predictive of the subsequent development of KS [4, 5] . However, KSHV/HHV-8 DNA has also been reported to be preva-IFA [14] . More recently, an EBV-negative KSHV/HHV-8 -infected BCP-1 cell line was used by Gao et al. [15] to detect lent in semen of healthy men [6, 7], and KSHV/HHV-8 sequences have been associated with diseases other than KS KSHV/HHV-8 -related antibodies, and the presence of antibodies was found to correlate well with the presence of KS. [8 -10], indicating that the KS may arise in only a subset of infected people.
The wide variation in the incidence of Kaposi's sarcoma rials for viral sequences by PCR. PCR-based assays require that the specific tissue being examined contain viral genomes (KS) among particular human immunodeficiency virus type 1 (HIV-1) -infected risk groups and other epidemiologic eviand, therefore, can fail to detect virus when viremia is intermittent or there are low genome copy numbers [5] . Moreover, as dence has suggested KS might be caused by an infectious agent [1, 2] . The recent discovery of KS-associated herpesvirus/ pointed out by others, the ease of sample contamination provides another potential drawback of PCR [11 -13] . human herpesvirus type 8 (KSHV/HHV-8) and the detection of its DNA in nearly all KS lesions from people with AIDS A specific and sensitive serologic assay for antibodies to KSHV/HHV-8 would reveal the demographics of infection and people in other patient groups [3] have provided evidence that this virus plays an important role in the pathogenesis of with this virus without regard to disease manifestations or sites of infection. Development of a serologic assay has been hin-KS. Further evidence of its etiologic relationship to KS was provided by the observation that detection of KSHV/HHV-8 dered by the significant sequence homology between KSHV/ HHV-8 and Epstein-Barr virus (EBV). Expression of KSHV/ DNA in peripheral blood mononuclear cells (PBMC) of HIV-1 -positive patients by polymerase chain reaction (PCR) HHV-8 antigens in HBL-6 cells along with the removal of EBV -cross-reactive antibodies allowed the development of an is predictive of the subsequent development of KS [4, 5] . However, KSHV/HHV-8 DNA has also been reported to be preva-IFA [14] . More recently, an EBV-negative KSHV/HHV-8 -infected BCP-1 cell line was used by Gao et al. [15] to detect lent in semen of healthy men [6, 7] , and KSHV/HHV-8 sequences have been associated with diseases other than KS KSHV/HHV-8 -related antibodies, and the presence of antibodies was found to correlate well with the presence of KS. [8 -10] , indicating that the KS may arise in only a subset of infected people.
Also, an IFA using isolated nuclei from a KSHV/HHV-8 -infected BCBL-1 cell line was developed and provided evi-A complete description of the epidemiology of KSHV/ HHV-8 and its possible role in the pathogenesis of KS and dence of KSHV/HHV-8 as a sexually transmissible agent [13] .
While not ideal, these assays have yielded initial estimates of other diseases cannot be derived from surveys of clinical matethe seroprevalence of KSHV/HHV-8 infection.
In an attempt to mitigate the potential problems of antigen abundance and cross-reactivity, we developed an ELISA to detect KSHV/HHV-8 -specific antibodies. It is based on an patients enrolled in research protocols at the National Cancer Instiwas treated with N-succinimidyl S-acetylthioacetate (Pierce) to introduce sulfhydryl groups via a reaction through the primary tute (NCI) from April 1985 to December 1996. An additional 64 samples were obtained from hemophiliacs, blood donors, and amines of lysine. The activated peptide was combined with the modified BSA and incubated at 4ЊC overnight, followed by dehomosexual men as part of research protocols at the Viral Epidemiology Branch, NCI. Twelve samples with known titers for EBV, salting on a PD-10 column (Pharmacia, Piscataway, NJ). The peptide conjugate (1 mg/mL in PBS containing 1 mM EDTA) was including ones from patients with documented EBV-associated lymphoproliferative diseases, were collected from patients enrolled stored at 020ЊC in multiple aliquots until further use. Sequence analysis software (MacVector; Kodak, New Haven, CT) was used in research protocols at the Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases. Serum samto determine the antigenic index for regions of the predicted KSHV protein [17] . This method combines the information on hydrophilples from 8 children (ages 6 months to 5 years) were provided by N. Luban (Laboratory of Medicine, Children's National Medical icity, surface probability, and backbone flexibility in addition to secondary structure predictions to obtain a composite prediction Center, Washington, DC).
Of 68 HIV-1-positive patients for whom sera were analyzed, for antigenicity. Rabbit antibody production. For production of a rabbit poly-33 were KS negative, and 35 either had KS at the time of sampling (29 patients) or acquired documented KS within 1 year after the clonal antibody to the peptide, the peptide was conjugated to keyhole limpet hemocyanin (Sigma, St. Louis) by reaction with 0.1% sample date (6 patients). Samples were stored at 070ЊC prior to testing. Data on the detection of KSHV/HHV-8 DNA in PBMC glutaraldehyde in PBS for 2 h followed by dialysis against PBS. After 10 mL of blood was drawn from 2 rabbits, the animals were by PCR for some of the patients in this study were obtained as described previously [16] . In the present study, patients were coninjected subcutaneously with 500 mL of 0.5 mg/mL keyhole limpet hemocyanin conjugate emulsified with Freund's adjuvant. The rabsidered PCR positive for KSHV/HHV-8 if viral sequences were detected by Southern blot hybridization following at least two bits were boosted with three additional injections on days 14, 28, and 70. To affinity-purify antibodies directed to the 18-amino independent PCR reactions. EBV antibody titers were determined by H. Jensen of the University of Texas at San Antonio, using acid peptide, rabbit serum was applied to an NHS high trap column (Pharmacia) that contained 2 mg of the bound, unconjugated pepclassical immunofluorescent tests.
Peptide synthesis and conjugation. The 18-amino acid peptide. Unbound material was washed off the column, and the bound antibodies were then eluted with 100 mM glycine, pH 2.3, contide (molecular mass, 2160 Da) corresponding to aa 186-203 (RTYRLDVDNTDPRTALRV) of the putative minor capsid protaining 0.5 M NaCl. The antibody preparation was neutralized with 1 M TRIS to a final concentration of 100 mM and stored at 020ЊC tein of KSHV/HHV-8 [3] was prepared by G. Poy (NCI) using a hydroxy-methyl-phenoxyacetic acid resin on a synthesizer (model until further use. The affinity-purified antibody was tested for its ability to detect 431A; Applied Biosystems, Foster City, CA). The peptide was cleaved from the resin with trifluoroacetic acid, precipitated with the P1-BSA conjugate by Western blot analysis. Western blot was also done on the supernatants from cultures of KSHV/HHV-8-ether, dried under vacuum, and purified to ú95% purity by reversephase high-performance liquid chromatography (RP-HPLC), and infected BCBL-1 cells, an EBV-negative line [18] . For TPA induction, 10 6 BCBL-1 cells were incubated with 20 ng/mL TPA for its molecular mass was verified by electrospray mass spectrometry. The amino acid composition was confirmed by amino acid analy-48 h. The cells were then washed with fresh media and incubated for 2 more days. The supernatants were then collected, and virus sis.
For conjugation of the 18-amino acid peptide to bovine serum was pelleted by centrifugation at 26,000 g for 2 h, washed once with PBS, and pelleted again. To verify the presence of KSHV/ albumin (BSA), the amino terminus of the peptide was maleimideactivated using sulfosuccinimidyl 4-(N-maleimidomethyl) cyclo-HHV-8 in the cells and their pelleted supernatants, PCR analysis was done on DNA extracts as described previously [16] . For Westhexane-1-carboxylate, as described by the manufacturer (Pierce, Rockford, IL). The activated peptide was then purified using ern blot analysis of the proteins, the pelleted material was solubilized in SDS sample buffer, boiled at 95ЊC for 5 min, applied to RP-HPLC to remove excess reagent. Pyrogen-poor BSA (Pierce) 2B). Of importance, the affinity-purified rabbit antibody detected a 34-kDa (M r ) protein on Western blots of pelleted supernatant from the TPA-activated BCBL-1 cell line but not pelResults leted supernatants from nonactivated cells, and this band was eliminated by preincubation of the purified rabbit antibody with At the outset of this study, we sought to identify a unique region among the then known KSHV/HHV-8 open-reading purified unconjugated peptide (figure 2B). These results provide evidence that affinity-purified antibodies to P1 can detect frame (ORF) sequences that had a high probability of being / 9d27$$my38 03-13-97 11:46:52 jinfa UC: J Infect the native 34-kDa viral protein (predicted molecular mass, 34 without KS, as a whole, was significantly less than that of the KS patients (median OD, 0.207; P Å .018). A similar result kDa) from KSHV/HHV-8.
An ELISA was developed to test patients' sera for the preswas obtained if the KS patients' seroreactivity was compared with that of the HIV-1 -positive hemophiliacs without KS ence of KSHV/HHV-8 antibodies reactive with the P1-BSA conjugate. The ELISA was done using sera from 118 persons (group E; median OD, 0.155; P Å .004). Differences in reactivity dropped just below the level of significance (P Å .051), with or without KS (table 1). A dose-response curve was obtained for all patients by serial dilution of sera from 1:25 to however, if we compared the HIV-1 -negative blood donors (group B) with the HIV-1 -positive homosexual patients 1:12,800. Representative dose-response curves for patients with high, medium, and low responses are shown in figure 3 . These with KS. Assuming that the ELISA results from childrens' sera are curves are all roughly parallel, and we elected to use the OD at a 1:50 dilution for further analyses. The overall results using indicative of negative responses to P1-BSA (group A, figure 4), we established a positive antibody response as being a value data from the 1:25 or the 1:100 dilutions were essentially the same.
greater than the mean / 2 SD (OD of 0.36 at the 1:50 serum dilution). Using this cutoff, we found that 21 (60%) of the 35 As shown in figure 4 To estimate the sensitivity of this ELISA for KSHV/ HHV-8 infection, we examined the serologic findings for a subset of HIV-1 -positive patients with KS whose PBMC were previously positive for KSHV/HHV-8 DNA by PCR. Of 14 such PCR-positive patients, 9 (64%) were also antibody positive by ELISA. By contrast, none of the 5 HIV-1 -positive patients without KS who tested negative by PCR were ELISA positive for the KSHV/HHV-8 P1-BSA.
We looked for a relationship between the response in the ELISA for the KSHV/HHV-8 P1-BSA and the CD4 cell count among HIV-1 -positive patients (with and without KS) for whom we had CD4 cell counts. However, no significant corre- protein containing P1, we considered it important to verify that rabbit antibody to P1 peptide, and immunoreactive proteins were the reactivity toward the P1 conjugate was not simply a reflecdetected using goat anti-rabbit antibody conjugated to alkaline phostion of antibodies to EBV in the patients' sera. To do this, we phatase. B, Blot was incubated with 5 mg/mL affinity-purified antibody to P1 peptide, which had been preincubated for 6 h with 25 mg measured antibodies to the P1-BSA conjugate in 12 patients of purified P1 peptide, followed by clarification by centrifugation. whose sera spanned a wide range of EBV titers. We also determined the EBV titers of 6 patients identified as having a range of antibody response to P1-BSA. There was no significant (figure 4, group D, ᭺), while the remaining patients in that correlation (r s Å 0.345; P Å .158) between the response to group have remained KS negative to date. Of the 30 healthy the P1-BSA conjugate and the titer for the IgG antibodies to blood donors (group B), 6 (20%) were antibody positive for the EBV viral capsid antigen ( figure 5 ). In fact, the correlation KSHV/HHV-8, which was not significantly different from the coefficient had a negative trend (00.345), suggesting a ten-HIV-1 -positive patients without KS (figure 4, groups D and dency for patients with higher EBV antibody titers to have E). It should be noted that several of the blood donors and lower ELISA responses to P1 (figure 5). Moreover, 2 of the HIV-1 -positive patients without KS (n Å 8) reacted strongly patients with the highest EBV titers had a very weak response to the P1 conjugate, while 2 patients seronegative for EBV to the P1-BSA conjugate (ú1.0 OD unit; figure 4). (titers for viral capsid antigen õ1:10) had a moderate or high [13, 25] . Although these assays have yielded initial estimates of the seroprevalence of KSHV/HHV-8 infection, the antigens response to P1 (figure 5). Similarly, we found no correlation in these tests are not well defined, and the interpretation of the between the response to P1 conjugate and the titers of antibodresults are subjective. More recently, serologic tests utilizing ies to other EBV antigens, including early antigens and EBV recombinant capsid-related proteins from KSHV/HHV-8 were nuclear antigens (data not shown). Taken together, these results reported [26, 27] . strongly suggest that antibodies to EBV proteins do not crossIn this study, we developed an ELISA to detect antibodies react to P1-BSA and are not responsible for the observed to a predicted peptide sequence of a putative minor capsid ELISA responses.
antigen of KSHV/HHV-8. If KSHV/HHV-8 is sexually transmitted, which has been supported [13], we hypothesized that young children were likely to be seronegative for this virus Discussion because they generally are for most other herpesviruses. ThereUntil very recently, PCR analysis of DNA from patients has fore, we assayed a cutoff value for a positive ELISA result as been the primary method of assessing infection with KSHV/ one that is significantly higher (2 SDs) than the mean results for HHV-8 [3 -5, 7, 16, 21 -23] . However, the conclusions drawn the children. This assumption could lead to an underestimate of from these studies vary widely, and the prevalence of KSHV/ the true seroprevalence of KSHV/HHV-8, however, if some HHV-8 infection remains uncertain. PCR can, because of low young children are infected by the virus or retain some maternal levels of viral sequences in the circulation or assayed tissue antibodies to it. [11, 12] , underestimate the proportion of those infected with
We found that KS patients had a higher level of antibodies KSHV/HHV-8, and PCR studies may not identify patients who than did subjects in other cohorts. Using the cutoff described, harbor the virus only transiently or in selected anatomic sites.
we detected antibodies in 60% of the HIV-1 -positive patients Furthermore, sample contamination is a recognized problem with KS and 27% of the HIV-1 -positive patients without KS. with PCR and results in an overestimation of the number of
The results within the HIV-1 -positive groups compare closely infected people. To better characterize the rate of KSHV/ with those of Miller et al. [24] , who reported that antibodies HHV-8 infection, indirect IFAs and immunoblot assays were to KSHV/HHV-8 lytic antigens, as assayed by an immunoblot recently developed to detect viral antibodies, using antigens assay, were detected by Western blot in 67% of KS patients from KSHV/HHV-8 -infected cell lines [13 -15, 24] . The IFAs, and in 13% of HIV-1 -positive patients without KS. which are believed to detect latent KSHV/HHV-8 nuclear antiPrevious studies using PCR technology suggested that gens, have yielded 80% -83% seropositivity for patients with KSHV/HHV-8 DNA could be detected in circulating PBMC from 35% to 52% of KS patients [5, 16] . However, KSHV/ KS, but õ2% of normal blood donors were seropositive / 9d27$$my38 03-13-97 11:46:52 jinfa UC: J Infect tive homosexual patients whose KS was first reported within 1 year after the sample date (and 1 additional homosexual patient diagnosed with KS 13 months after the sample date) had antibodies to P1-BSA, suggesting that a burst of lytic infection might closely precede the development of KS. Thus, the ELISA response of sera from HIV-1 -positive homosexuals to P1-BSA may be predictive of the subsequent development of KS. Prospective studies will be needed to better understand the factors affecting the production of antibodies to P1-BSA during the development of KS. Nevertheless, it is possible that the ELISA may be more sensitive for detecting acute or reactivated infections with KSHV/HHV-8 than for recognizing long-standing latent infections. A more provocative finding in the present study is that 20% of normal adult blood donors and 27% of hemophiliacs with HIV-1 infection had detectable antibodies to P1-BSA. Multiple groups have attempted to define the prevalence of KSHV/ HHV-8 infection in the general population. Using PCR-based analysis of DNA from PBMC [5, 16] (where KS is a more frequent malignancy in HIV-1-negative people than it is in the US). Overall, these HHV-8 DNA could be detected in Ç95% of KS lesions from patients with both HIV-1 -and non -HIV-1 -associated KS studies have yielded somewhat conflicting results, and many questions remain concerning the prevalence of KSHV/HHV-8 infec- [4, 8] . In KS patients previously found to harbor KSHV/ HHV-8 DNA in their PBMC, the detection rate of antibodies tion, particularly in the general population. If our ELISA is, in fact, specific for antibodies to KSHV/ to the P1-BSA conjugate in the present study was 64%. Overall, these results would seem to indicate that the present assay, like HHV-8, then it would predict that 20% -30% of the general US adult population is infected with KSHV/HHV-8. This is that of Miller et al. [24] , does not detect antibodies in all HIV-1 -positive patients who may also be infected with KSHV/ higher than the seropositivity rates recently reported using IFAs utilizing latent antigens or by using a recently developed re-HHV-8. Why might this be? In regard to our assay, one possibility is that it is based on a restricted antigenic epitope to combinant capsid protein assay [26] . However, it is in close agreement with a recent report by Lennette et al. [33] indicating which patients with particular HLA haplotypes may not mount strong antibody responses. Another possibility is that HIV-1 -that 25% of adults (and 2% -8% of children) had antibodies to lytic HHV-8 antigens as detected by IFA. These results are positive patients have a limited ability to produce antibodies to new antigens [28] , and this may have decreased the proporalso in accord with rates of seropositivity in the United States to herpes simplex virus 2, the prototypical sexually transmitted tion of seropositive patients because of some who might have been first infected with KSHV only after being infected with herpesvirus, but are substantially lower than the seroprevalence of cytomegalovirus, another lymphotropic herpesvirus [34] . It HIV-1.
A third factor that could limit the sensitivity of our ELISA is possible that the present ELISA overestimates KSHV/ HHV-8 seroprevalence by virtue of cross-reactions to an as is that the peptide utilized is part of a KSHV/HHV-8 protein, which like its EBV homolog, is expressed only during lytic yet undetermined antigen. Cross-reactivity would have to be presumed if recent reports of KSHV/HHV-8 -related antibodinfection. The 34-kDa protein was detected by the purified rabbit antibody to P1 in only the TPA-stimulated cellular superies in £1% of North American blood donors are eventually proven correct [13, 15] . A number of the IFAs are believed to natant, which is consistent with it being a lytic protein (figure 2). If KSHV/HHV-8 lytic replication ends with resolution of detect antibodies to latent, rather than lytic, antigens of KSHV/ HHV-8, and, therefore, the differences seen between the results the primary infection, then antibodies to P1 may eventually decline to undetectable levels. Of interest, 5 of 6 HIV-1 -posiof our studies and those of others may reflect the abundance JID 1997;175 (May) In the present study, we utilized a synthetic peptide repre- cross-reactivity with other antibodies in serum. reacted with sera from 60% of KS patients. Now that the entire
